Literature DB >> 11895625

Hymenoptera (apid and vespid) allergy: update in diagnosis and management.

Gerald W Volcheck1.   

Abstract

Allergic reactions to Hymenoptera stings range from large local reactions to life-threatening anaphylaxis. Over the last 20 years, significant progress has been made using venom extracts in the diagnosis and treatment of Hymenoptera allergy. Despite these advances, there is still room for improvement in increasing the sensitivity of venom allergen skin testing. The venom allergic patient with negative skin tests poses special problems in management. It is important to note their increased risk with a subsequent sting. Guidelines to be used in determining the duration of venom immunotherapy are still evolving. Knowledge of the risks of discontinuing venom immunotherapy and risk factors associated with anaphylaxis with subsequent stings are required to form an individualized approach to treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11895625     DOI: 10.1007/s11882-002-0037-7

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  29 in total

1.  Insect sting anaphylaxis in patients without detectable serum venom-specific IgE.

Authors:  W F Clayton; J W Georgitis; R E Reisman
Journal:  Clin Allergy       Date:  1985-07

2.  Dose dependence of Hymenoptera venom immunotherapy.

Authors:  D B Golden; A Kagey-Sobotka; M D Valentine; L M Lichtenstein
Journal:  J Allergy Clin Immunol       Date:  1981-05       Impact factor: 10.793

3.  Stinging insect hypersensitivity: a practice parameter. The Joint Force on Practice Parameters, the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology.

Authors:  J M Portnoy; J E Moffitt; D B Golden; W E Bernstein; M S Dykewicz; S M Fineman; R E Lee; J T Li; R A Nicklas; D E Schuller; S L Spector
Journal:  J Allergy Clin Immunol       Date:  1999-05       Impact factor: 10.793

4.  Epidemiology of insect venom sensitivity.

Authors:  D B Golden; D G Marsh; A Kagey-Sobotka; L Freidhoff; M Szklo; M D Valentine; L M Lichtenstein
Journal:  JAMA       Date:  1989-07-14       Impact factor: 56.272

5.  Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious.

Authors:  A Goldberg; R Confino-Cohen
Journal:  J Allergy Clin Immunol       Date:  2001-05       Impact factor: 10.793

6.  The Hymenoptera venom study. II: Skin test results and safety of venom skin testing.

Authors:  R F Lockey; P C Turkeltaub; C A Olive; I A Baird-Warren; E S Olive; S C Bukantz
Journal:  J Allergy Clin Immunol       Date:  1989-12       Impact factor: 10.793

7.  Venom skin tests in insect-allergic and insect-nonallergic populations.

Authors:  J W Georgitis; R E Reisman
Journal:  J Allergy Clin Immunol       Date:  1985-12       Impact factor: 10.793

8.  Natural history of insect sting allergy: relationship of severity of symptoms of initial sting anaphylaxis to re-sting reactions.

Authors:  R E Reisman
Journal:  J Allergy Clin Immunol       Date:  1992-09       Impact factor: 10.793

9.  Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom.

Authors:  U Müller; C A Akdis; M Fricker; M Akdis; T Blesken; F Bettens; K Blaser
Journal:  J Allergy Clin Immunol       Date:  1998-06       Impact factor: 10.793

10.  Natural history of large local reactions from stinging insects.

Authors:  P M Mauriello; S H Barde; J W Georgitis; R E Reisman
Journal:  J Allergy Clin Immunol       Date:  1984-10       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.